Dr. med. Jochen Vehoff
chief of service
Neurologie · Dept. III
Das reversible zerebrale Vasokonstriktionssyndrom
Beerle N, Hader C, Kleger G, Kägi G, Vehoff J. Das reversible zerebrale Vasokonstriktionssyndrom. Swiss Medical Forum 2019; 19:232-236.
Mar 27, 2019Das reversible zerebrale Vasokonstriktionssyndrom
Mar 27, 2019Swiss Medical Forum 2019; 19:232-236
Beerle Nicolas, Hader Claudia, Kleger Gian-Reto, Kägi Georg, Vehoff Jochen
The impact of implementing a “fast-track” algorithm on time to treatment and outcome in patients with acute ischemic stroke due to large vessel occlusion
Velicky M, Brugger F, Kägi G, Weber J, Vehoff J (2019). The impact of implementing a “fast-track” algorithm on time to treatment and outcome in patients with acute ischemic stroke due to large vessel occlusion.
Jan 16, 2019The impact of implementing a “fast-track” algorithm on time to treatment and outcome in patients with acute ischemic stroke due to large vessel occlusion
Jan 16, 201922. SHG Jahrestagung
Velicky Matus, Brugger Florian, Kägi Georg, Weber Johannes, Vehoff Jochen
Retrospective comparison of the outcome of patients, treated with intravenous thrombolysis with unknown versus known symptom onset, guided by CT-imaging
Brugger F, Weber J, Kägi G, Vehoff J (2019). Retrospective comparison of the outcome of patients, treated with intravenous thrombolysis with unknown versus known symptom onset, guided by CT-imaging.
Jan 16, 2019Retrospective comparison of the outcome of patients, treated with intravenous thrombolysis with unknown versus known symptom onset, guided by CT-imaging
Jan 16, 201922. SHG Jahrestagung
Brugger Florian, Weber Johannes, Kägi Georg, Vehoff Jochen
Multiple Sklerose: Neues zur monoklonalen Antikörpertherapie
Uffer D, Müller S, Vehoff J. Multiple Sklerose: Neues zur monoklonalen Antikörpertherapie. InFo Neurologie & Psychiatrie 2018; 1:15-18.
Mar 25, 2018Multiple Sklerose: Neues zur monoklonalen Antikörpertherapie
Mar 25, 2018InFo Neurologie & Psychiatrie 2018; 1:15-18
Uffer Denis, Müller Stefanie, Vehoff Jochen
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.
Seiffge D, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sándor P, Rodier G, Zini A, Cappellari M, Schaedelin S, Polymeris A, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis G, Peters N, Sirimarco G, Bonati L, Arnold M, Lyrer P, De Maistre E, Luft A, Tsakiris D, Engelter S, Novel Oral Anticoagulants in Stroke Patients study group. Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage. Ann Neurol 2018; 83:451-459.
Mar 3, 2018Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.
Mar 3, 2018Ann Neurol 2018; 83:451-459
Seiffge David Julian, Kägi Georg, Michel Patrik, Fischer Urs, Béjot Yannick, Wegener Susanne, Zedde Marialuisa, Turc Guillaume, Cordonnier Charlotte, Sándor Peter S, Rodier Gilles, Zini Andrea, Cappellari Manuel, Schaedelin Sabine A, Polymeris Alexandros A, Werring David J, Thilemann Sebastian, Maestrini Ilaria, Berge Eivind, Traenka Christopher, Vehoff Jochen, De Marchis Gian Marco, Peters Nils, Sirimarco Gaia, Bonati Leo H, Arnold Marcel, Lyrer Philippe A, De Maistre Emmanuel, Luft Andreas R, Tsakiris Dimitrios A, Engelter Stefan T, Novel Oral Anticoagulants in Stroke Patients study group
Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry
Traenka C, Steiner L, Kägi G, Luft A, Sztajzel R, Fischer U, Bonati L, Peters N, Michel P, Lyrer P, Arnold M, Wegener S, Weber J, Vehoff J, Jung S, Gralla J, Kurmann R, Stippich C, Goeggel Simonetti B, Gensicke H, Mueller H, Lovblad K, Eskandari A, Puccinelli F, Engelter S. Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry. European Stroke Journal 2018; 3:47-56.
Jan 3, 2018Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry
Jan 3, 2018European Stroke Journal 2018; 3:47-56
Traenka Christopher, Steiner Levke, Kägi Georg, Luft Andreas, Sztajzel Roman, Fischer Urs, Bonati Leo H, Peters Nils, Michel Patrik, Lyrer Philippe A, Arnold Marcel, Wegener Susanne, Weber Johannes, Vehoff Jochen, Jung Simon, Gralla Jan, Kurmann Rebekka, Stippich Christoph, Goeggel Simonetti Barbara, Gensicke Henrik, Mueller Hubertus, Lovblad Karl-Olof, Eskandari Ashraf, Puccinelli Francesco, Engelter Stefan T
Heart rate variability decreases after 3 months of sustained treatment with fingolimod
Vehoff J, Haegele-Link S, Humm A, Mueller S, Sauter R, Tettenborn B, Hundsberger T. Heart rate variability decreases after 3 months of sustained treatment with fingolimod. J Neurol 2017; 264:2313-2317.
Oct 9, 2017Heart rate variability decreases after 3 months of sustained treatment with fingolimod
Oct 9, 2017J Neurol 2017; 264:2313-2317
Vehoff Jochen, Haegele-Link Stefan, Humm Andrea, Mueller Stefanie Karin, Sauter Rafael, Tettenborn Barbara, Hundsberger Thomas
Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
Vehoff J, Hägele-Link S, Humm A, Müller S, Sauter R, Tettenborn B, Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial.
Jun 25, 2017Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
Jun 25, 20173rd EAN Congress
Vehoff Jochen, Hägele-Link Stefan, Humm Andrea, Müller Stefanie, Sauter Rafael, Tettenborn Barbara, Hundsberger Thomas
Akutbehandlung des ischämischen Schlaganfalls
Vehoff J, Kägi G. Akutbehandlung des ischämischen Schlaganfalls. InFo Neurologie & Psychiatrie 2017 2017; Vol.15:8-11.
Jan 1, 2017Akutbehandlung des ischämischen Schlaganfalls
Jan 1, 2017InFo Neurologie & Psychiatrie 2017 2017; Vol.15:8-11
Vehoff Jochen, Kägi Georg
Der akute Schlaganfall
Kägi G, Vehoff J. Der akute Schlaganfall - Vom nicht behandelbaren Schicksal zur therapeutischen Erfolgsgeschichte. info@herz+gefäss 2016; Vol. 6:20-22.
Nov 1, 2016Der akute Schlaganfall
Nov 1, 2016info@herz+gefäss 2016; Vol. 6:20-22
Kägi Georg, Vehoff Jochen
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Gass A, Würfel J, Ruberte E, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. Eur J Neurol 2016
Sep 3, 2016The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography
Sep 3, 2016Eur J Neurol 2016
Pardini M, Putzki N, Tettenborn Barbara, Valmaggia Christophe, Gass A, Würfel J, Ruberte E, Kuhle J, Vehoff Jochen, Müller Stefanie, Botzkowski D, Yaldizli O
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
Mar 31, 2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Mar 31, 2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board
Glioblastoma multiforme: Chameleon of neurology A case report
Prochnicki A, Zieglgänsberger D, Vehoff J, Müller S, Tettenborn B, Hundsberger T (2015). Glioblastoma multiforme: Chameleon of neurology A case report.
Oct 30, 2015Glioblastoma multiforme: Chameleon of neurology A case report
Oct 30, 2015SNG Tagung 2015
Prochnicki Anita, Zieglgänsberger Dominik, Vehoff Jochen, Müller Stefanie, Tettenborn Barbara, Hundsberger Thomas
Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Würfel J, Gass A, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study.
Oct 7, 2015Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Oct 7, 2015ECTRIMS 2015
Pardini M., Putzki Norman, Tettenborn Barbara, Valmaggia Christophe, Würfel Jens, Gass Andrea, Kuhle Jens, Vehoff Jochen, Müller Stefanie, Botzkowski D., Yaldizli Ozgür
The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs
Disanto G, Derfuss T, Louvion J, Kamm C, Mattle H, Lotter C, du Pasquier R, Schluepp M, Pot C, Lalive P, Kappos L, Stippich C, Sprenger T, Benkert P, Lohrscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achnichts L, Findling O, Nedeltchev K, Radue E, Kuhle J (2015). The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs.
Sep 23, 2015The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs
Sep 23, 2015ECTRIMS 2015
Disanto G., Derfuss T., Louvion J.-F., Kamm C., Mattle H.P., Lotter C., du Pasquier R., Schluepp M., Pot C., Lalive P.H., Kappos L., Stippich C., Sprenger T., Benkert P., Lohrscheider J., Müller Stefanie, Vehoff Jochen, Zecca C., Ramseier S., Achnichts L., Findling O., Nedeltchev K., Radue E.W., Kuhle J.
Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Döhler N, Müller S, Vehoff J, Galovic M, Tettenborn B (2014). Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Sep 10, 2014Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Sep 10, 2014ECTRIMS 2014
Döhler Nico, Müller Stefanie, Vehoff Jochen, Galovic Marian, Tettenborn Barbara
Autonomic Dysfunction in Cancer Cachexia Coincides With Large Fiber Polyneuropathy
Hundsberger T, Omlin A, Hägele-Link S, Vehoff J, Strasser F. Autonomic Dysfunction in Cancer Cachexia Coincides With Large Fiber Polyneuropathy. J Pain Symptom Manage 2014; 48:611-618.
Apr 4, 2014Autonomic Dysfunction in Cancer Cachexia Coincides With Large Fiber Polyneuropathy
Apr 4, 2014J Pain Symptom Manage 2014; 48:611-618
Hundsberger Thomas, Omlin Aurelius, Hägele-Link Stefan, Vehoff Jochen, Strasser Florian
Akuttherapie auf der Stroke-Unit. Time is brain – Warum rasch einweisen?
Mähr S, Stauber A, Vehoff J, Kägi G, Weber J, Tettenborn B. Akuttherapie auf der Stroke-Unit. Time is brain – Warum rasch einweisen?. InFo Neurologie & Psychiatrie. Ausgabe 2, Seite 4-6, Februar 2014 2014; Ausgabe 2:4-6.
Feb 1, 2014Akuttherapie auf der Stroke-Unit. Time is brain – Warum rasch einweisen?
Feb 1, 2014InFo Neurologie & Psychiatrie. Ausgabe 2, Seite 4-6, Februar 2014 2014; Ausgabe 2:4-6
Mähr Sabrina, Stauber Anna Julia, Vehoff Jochen, Kägi Georg, Weber Johannes, Tettenborn Barbara
Highlights vom ECTRIMS-Kongress 2013
Vehoff J, Tettenborn B, Mueller S. Highlights vom ECTRIMS-Kongress 2013. InFo Neurologie & Psychiatrie 2014; Ausgabe 1:42-45.
Jan 1, 2014Highlights vom ECTRIMS-Kongress 2013
Jan 1, 2014InFo Neurologie & Psychiatrie 2014; Ausgabe 1:42-45
Vehoff Jochen, Tettenborn Barbara, Mueller Stefanie
Update Schlaganfall 2013
Vehoff J, Tettenborn B, Kägi G. Update Schlaganfall 2013. der informierte @rzt 2013; Ausgabe 11:10-13.
Nov 1, 2013Update Schlaganfall 2013
Nov 1, 2013der informierte @rzt 2013; Ausgabe 11:10-13
Vehoff Jochen, Tettenborn Barbara, Kägi Georg